Lebrikizumab Wins FDA Approval for Eczema
MedPage Today) -- The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and...
MedPage Today) -- The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and...
Stanford Medicine researchers and their colleagues have found that choosing treatments based on the type of a patient's depression increases...